DTB Select: Updated evidence for oral mucolytics in COPD

Summary and context is provided for a update to an earlier Cochrane review of 38 RCTs (n=10,377) suggesting treatment with mucolytics leads to a small reduction in likelihood of having an exacerbation of COPD, and in days of disability per month with no increase in adverse events


Drug and Therapeutics Bulletin